
Eli Lilly Nails Oral GLP-1 Trial — Here’s What It Means for the Stock
The world’s largest pharmaceutical stock, Eli Lilly and Company (NYSE:LLY), is back in the green in 2025 as of the Apr. 21 close. Shares were down moderately in 2025 through mid-April. However, huge news came out regarding one of the company’s experimental …